GEHC Reports Q1 2026 Revenue of $5.1 Billion with 2.9% Growth

GE HealthCare Technologies (GEHC) reported Q1 2026 revenue of $5.1 billion, reflecting a 2.9% organic growth year over year. The company noted a record backlog of $21.8 billion and a book-to-bill ratio of 1.07x. However, management reduced full-year profit guidance due to $250 million in gross inflation and a supplier-related recall, adjusting EPS to between $4.80 and $5.00 while projecting free cash flow of approximately $1.6 billion. Additionally, revenue increased in EMEA and other regions, but U.S. growth experienced mid-single digits, and China revenue improved sequentially despite a year-over-year decline.